Based on our advanced algorithm, we predict that GDTC stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $1.87, while the 1-week outlook suggests a value of $1.83. For the 1-month forecast, we project a price of $1.88. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GDTC has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
GDTC stock price ended at $1.85 on Thursday, after rising5.71%
The CytoMed Therapeutics Ltd stock price increased by 5.71% on the last trading day (04 Dec 2025), rising from 1.75 to 1.85. Throughout the last trading session, the stock experienced a fluctuation of 7.42% , ranging from a day low of $1.75 to a day high of 1.8798. The price has declined in 5 of the last 10 days, resulting in a total change of 2.21% during this period. On the last day, trading volume decrease by -3.24K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.17K shares were traded, amounting to approximately 2.04K.
GDTC Technical Signals
GDTC(CytoMed Therapeutics Ltd Corp) has 4 buy signals and 2 sell signals now. The current trend is an uptrend starting from 2025-11-20. The total price change during this trend is +2.78%. Recently, the price has increased while volume droped, indicating a potential warning signal. The average turnover of GDTC over the last 5 trading days is 21.08K. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
GDTC Moving Average Analysis
CytoMed Therapeutics Ltd's overall moving average trend leans more bearish as of Friday, December 5, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $2.01, and $2.11. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.69, and $1.59. A break-down below any of these levels will issue sell signals.
GDTC Short Selling Analysis
The short sale ratio of CytoMed Therapeutics Ltd(GDTC) as of 03 Dec 2025 is 22.73%, rising from last trading day. With increasing price from 1.74 to 1.75. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
2
Buy
4
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
9.357
Bullish
Momentum (10 days)
MOM_10 > 0
0.04
Bullish
Moving Average
Price crosses above 5-day SMA
--
Bullish
Moving Average
Price crosses above 10-day SMA
--
Bullish
2 Bearish Signals
2 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, CytoMed Therapeutics Ltd (GDTC) is anticipated to change hands in a trading channel between $0.00 and $0.00.
CytoMed Therapeutics Ltd Stock Forecast 2026
GDTC Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to CytoMed Therapeutics Ltd(GDTC), our algorithm predicts GDTC's 1-month price at $2.46, with an 33.88%upwardshift. Using a similarity score up to 97.45%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for CytoMed Therapeutics Ltd (GDTC.O) stock, as of Monday, December 1, 2025 , forecasts a 33.88% change over the next month, based on its high correlation with VCIG.O stock patterns. The similarity between their price movements over the analyzed periods is 97.45%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
GDTC
No Data
VCIG
Up: 33.88%Similarity: 97.45%
Name
Similarity
Up/Down
VCIG.O
97.45%
+33.88%
TCRT.O
97.13%
-2.23%
BKKT.N
97.11%
-57.36%
HUMA.O
97.01%
+2.42%
SMID.O
96.87%
-5.24%
PTLE.O
96.85%
+3.58%
FOSL.O
96.81%
-1.12%
SLRX.O
96.76%
-35.25%
PATH.N
96.75%
-6.00%
OPEN.O
96.73%
-35.97%
GDTC Seasonality Analysis
Based on GDTC's historical stock price data across all years, the probability of a positive return in December is100.00%, suggesting it maybe an ideal month to invest in GDTC. In contrast,Octoberoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying CytoMed Therapeutics Ltd (GDTC.O) stock in October has the highest probability of a positive return (100.00%), while January has the lowest probability (0.00%).
Performance Seasonality
The chart shows CytoMed Therapeutics Ltd. (GDTC)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy CytoMed Therapeutics Ltd (GDTC.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GDTC has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying CytoMed Therapeutics Ltd (GDTC.O) stock in a year?
The radar chart shows that buying CytoMed Therapeutics Ltd (GDTC.O) stock in October has the highest probability of a positive return (100.00%), while January has the lowest probability (0.00%).
How has CytoMed Therapeutics Ltd. (GDTC)'s stock price performed over the past three years?
GDTC's stock price rose by 22.50% in 2023,decreased by -22.90% in 2024, and went down by 47.14%in 2025.
Is GDTC a buy based on overall technical signals summary?
GDTC has 4 buy signals and 2 sell signals now. Overall the technical rating for GDTC is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of GDTC.
What is the trend of CytoMed Therapeutics Ltd (GDTC)'s moving average?
CytoMed Therapeutics Ltd's overall moving average trend leans more bearish as of December 05 2025, with 3 negative signals and 1 positive signal.
What is price prediction for GDTC stock next month?
The price prediction chart for CytoMed Therapeutics Ltd (GDTC.O) stock, as of December 01 2025, forecasts a 33.88% change over the next month, based on its high correlation with VCIG stock patterns. The similarity between their price movements over the analyzed periods is 97.45%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2026 for CytoMed Therapeutics Ltd (GDTC) Stock?
In , CytoMed Therapeutics Ltd's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.
What is price prediction 2030 for CytoMed Therapeutics Ltd (GDTC) Stock?
In , CytoMed Therapeutics Ltd's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.